7-Nitroindazole, but not L-NAME or aminoguanidine, attenuates anaphylactic hypotension in conscious rats

Shock

Volumn 31, Issue 2, 2009, Pages 201-206

  Zhang, Wei ^a   Shibamoto, Toshishige ^a   Cui, Sen ^a   Takano, Hiromichi ^a   Kurata, Yasutaka ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

7 NI; Aminoguanidine; Anaphylactic shock; L NAME; Portal venous pressure

Indexed keywords

7 NITROINDAZOLE; AMINOGUANIDINE; ANTIGEN; INDUCIBLE NITRIC OXIDE SYNTHASE; N(G) NITRO DEXTRO ARGININE METHYL ESTER; N(G) NITROARGININE METHYL ESTER; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE; OVALBUMIN;

ANAPHYLAXIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; HYPOTENSION; MALE; NONHUMAN; OUTCOME ASSESSMENT; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; RAT; SPRAGUE DAWLEY RAT;

ANAPHYLAXIS; ANIMALS; ANTIGENS; ENZYME INHIBITORS; GUANIDINES; HYPOTENSION; INDAZOLES; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE TYPE II; PRESSURE; RATS; RATS, SPRAGUE-DAWLEY; SHOCK; TIME FACTORS;

EID: 59649110295     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e31817c05bc     Document Type: Article

References (35)

1. Kemp SF, Lockey RF: Anaphylaxis: a review of causes and mechanisms. J Allergy Clin Immunol 110:341-348, 2002.
2. Brown ATF: Anaphylactic shock: mechanisms and treatment. J Accid Emerg Med 12:89-100, 1995.
3. G -nitro-L-arginine-methyl ester, improves survival in anaphylactic shock. Eur J Pharmacol 203:125-127, 1991.
4. Cauwels A, Janssen B, Buys E, Sips P, Brouckaert P: Anaphylactic shock depends on PI3K and eNOS-derived NO. J Clin Invest 116:2244-2251, 2006.
5. Bellou A, Lambert H, Gillois P, Montémont C, Gerard P, Vauthier E, Sainte-Laudy J, Longrois D, Guéant JL, Mallié JP: Constitutive nitric oxide synthase inhibition combined with histamine and serotonin receptor blockade improves the initial ovalbumin-induced arterial hypotension but decreases the survival time in Brown Norway rats anaphylactic shock. Shock 19:71-78, 2003.
6. Mitsuhata H, Saitoh J, Hasome N, Takeuchi H, Horiguchi Y, Shimizu R: Nitric oxide synthase inhibition is detrimental to cardiac function and promotes bronchospasm in anaphylaxis in rabbits. Shock 4:143-148, 1995.
7. Muldoon SM, Hart JL, Bowen KA, Freas W: Attenuation of endothelium-mediated vasodilation by halothane. Anesthesiology 68:31-37, 1988.
8. Hart JL, Jing M, Bina S, Freas W, Van Dyke RA, Muldoon SM: Effects of halothane on EDRF/cGMP-mediated vascular smooth muscle relaxations. Anesthesiology 79:323-331, 1993.
9. Nathan C: Inducible nitric oxide synthase: what difference does it make? J Clin Invest 100:2417-2423, 1997.
10. Sade K, Schwartz I, Schwartz D, Wolman Y, Chemichovski T, Fireman E, Iaina A, Kivity S: Effect of montelukast pretreatment on inducible nitric oxide synthase mRNA expression in the lungs of antigen-challenged allergic mice. Clin Exp Allergy 33:1741-1746, 2003.
11. Zanzinger J, Czachurski J, Seller H: Neuronal nitric oxide reduces sympathetic excitability by modulation of central glutamate effects in pigs. Circ Res 80:565-571, 1997.
12. Kantzides A, Badoer E: nNOS-containing neurons in the hypothalamus and medulla project to the RVLM. Brain Res 1037:25-34, 2005.
13. Boulanger CM, Heymes C, Benessiano J, Geske RS, Levy BI, Vanhoutte PM: Neuronal nitric oxide synthase is expressed in rat vascular smooth muscle cells: activation by angiotensin II in hypertension. Circ Res 83:1271-1278, 1998.
14. Ichihara A, Inscho EW, Imig JD, Navar LG: Neuronal nitric oxide synthase modulates rat renal microvascular function. Am J Physiol Renal Physiol 274:F516-F524, 1998.
15. Toda N, Okamura T: The pharmacology of nitric oxide in the peripheral nervous system of blood vessels. Pharmacol Rev 55:271-324, 2003.
16. Mitsuhata H, Shimizu R, Yokoyama MM: Role of nitric oxide in anaphylactic shock. J Clin Immunol 15:277-283, 1995.
17. Saitoh J, Mitsuhata H, Takeuchi H, Hasome N, Shimizu R: In vivo production of nitric oxide in the canine heart in IgE-mediated anaphylaxis. Shock 6:66-70, 1996.
18. Sade K, Schwartz IF, Etkin S, Schwartzenberg S, Levo Y, Kivity S: Expression of inducible nitric oxide synthase in a mouse model of anaphylaxis. J Investig Allergoi Clin Immunol 17:379-385, 2007.
19. Shibamoto T, Cui S, Ruan Z, Liu W, Takano H, Kurata Y: Hepatic venoconstriction is involved in anaphylactic hypotension in rats. Am J Physiol Heart Circ Physiol 289:H1436-H1441, 2005.
20. Iadecola C, Xu X, Zhang F, Hu J, el-Fakahany EE: Prolonged inhibition of brain nitric oxide synthase by short-term systemic administration of nitro-L-arginine methyl ester. Neurochem Res 19:501-505, 1994.
21. Hua TC, Moochhala SM: Role of nitric oxide in hemorrhagic shock-induced bacterial translocation. J Surg Res 93:247-256, 2000.
22. Iadecola C, Xu S, Yang G: 7-Nitroindazole attenuates vasodilation from cerebellar parallel fiber stimulation but not acetylcholine. Am J Physiol 270: R914-R919, 1996
23. Sanyal RK, West GB: Anaphylactic shock in the albino rat. J Physiol 142:571-584, 1958.
24. Keller R, Jones VE: Immunological and pharmacological analysis of the primary and secondary reagin response to Nippostrongylus brasiliensis in the rat. Immunology 21:565-574, 1971.
25. Sun S, Weil MH, Tang W, Gazmuri RJ, Bisera J, Greenberg SR, Kim YB: Cardiac anaphylaxis in the Sprague-Dawley rat. J Lab Clin Med 120:589-596, 1992.
26. Mitsuhata H, Takeuchi H, Saitoh J, Hasome N, Horiguchi Y, Shimizu R: An inhibitor of nitric oxide synthase, Nomega-nitro-L-arginine-methyl ester, attenuates hypotension but does not improve cardiac depression in anaphylaxis in dogs. Shock 3:447-453, 1995.
27. G-nitro-L-arginine methyl ester potentiates anaphylactic venoconstriction in rat perfused livers. Clin Exp Pharmacol Physiol 33:1073-1077, 2006.
28. Moore PK, Wallace P, Gaffen Z, Hart SL, Babbedge RC: Characterization of the novel nitric oxide synthase inhibitor 7-nitroindazole and related indazoles: antinociceptive and cardiovascular effects. Br J Pharmacol 110:219-224, 1993.
29. Yoshida T, Limmroth V, Irikura K, Moskowitz MA: The NOS inhibitor, 7-nitroindazole, decreases focal infarct volume but not the response to topical acetylcholine in pial vessels. J Cereb Blood Flow Metab 14:924-929, 1994.
30. GMethyl-L-arginine, an inhibitor of L-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo: a role for nitric oxide in the central regulation of sympathetic tone? Circ Res 70:607-611, 1992.
31. Nishida Y, Chen QH, Tandai-Hiruma M, Terada S, Horiuchi J: Neuronal nitric oxide strongly suppresses sympathetic outflow in high-salt Dahl rats. J Hypertens 19:627-634, 2001.
32. Koyama S, Fujita T, Uematsu H, Shibamoto T, Aibiki M, Kojima S: Inhibitory effect of renal nerve activity during canine anaphylactic hypotension. Am J Physiol 258:R383-R387, 1990.
33. Mathison R, Befus AD, Davison JS: Hemodynamic changes associated with anaphylaxis in parasite-sensitized rats. Am J Physiol 258:H1126-H1131, 1990.
34. Kashiwagi S, Kajimura M, Yoshimura Y, Suematsu M: Nonendothelial source of nitric oxide in arterioles but not in venules: alternative source revealed in vivo by diaminofluorescein microfluorography. Circ Res 91: 55-64, 2002.
35. Montrucchio G, Alloatti G, Camussi G: Role of platelet-activating factor in cardiovascular pathophysiology. Physiol Rev 80:1669-1699, 2000.